×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

  • Gurus
  • Other
  • RA CAPITAL MANAGEMENT, L.P. (Data extracted from 13F, 13D, 13G and Form 4)

RA CAPITAL MANAGEMENT, L.P.

AUM: $11.32 B
13-F Portfolio Value: $11.51 B
Last 13-F Filed: Q2 2026
Concentration in top 10: 60.42%
Filter by:
Quarter to View:
Stock Company % Portfolio Shares Held Market Value Change in Shares % Change Quarter End Price Source
EWTXEDGEWISE THERAPEUTICS INC2.65%8,392,730$340,996,620-2,035,707-19.52%$40.6313F
SEPNSepterna, Inc.1.59%4,777,415$203,040,138-2,218,443-31.71%Form 4
GHRSGH Research PLC1.29%4,897,182$148,090,784-2,739,631-35.87%13G
NUVLNUVALENT INC-A1.20%1,246,456$153,937,316-1,287,689-50.81%$123.513F
GERNGERON CORP0.43%42,809,751$54,796,481-20,961,615-32.87%$1.2813F
AKTSAKTIS ONCOLOGY INC0.33%1,314,405$42,363,273-188,679-12.55%$32.2313F
OVIDOVID THERAPEUTICS INC0.22%10,500,968$28,247,604-213,032-1.99%$2.6913F
ACETADICET BIO INC0.06%932,624$8,057,871-250,000-21.14%$8.6413F
HOWLWEREWOLF THERAPEUTICS INC0.00668%2,387,744$859,349-4,293,563-64.26%$0.3613F
PTNPALATIN TECHNOLOGIES INC0.00521%62,124$670,318-7,876-11.25%$10.7913F